Cargando…
Clinical needs assessment to inform development of a new assay to detect antimalarial drugs in patient samples: A case study
Point-of-care assays have greatly increased access to diagnostic information and improved healthcare outcomes globally, especially in the case of tropical diseases in rural settings. Increased recognition of the impact of these tools and increased funding, along with advances in technology have led...
Autores principales: | Coonahan, Erin S., Amaratunga, Chanaki, Long, Carole A., Tarning, Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449106/ https://www.ncbi.nlm.nih.gov/pubmed/37616192 http://dx.doi.org/10.1371/journal.pgph.0002087 |
Ejemplares similares
-
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
por: Nguyen, Tran Dang, et al.
Publicado: (2023) -
Characterizing Blood-Stage Antimalarial Drug MIC Values In Vivo Using Reinfection Patterns
por: Watson, James, et al.
Publicado: (2018) -
Plasmodium falciparum Drug Resistance Phenotype as Assessed by Patient Antimalarial Drug Levels and Its Association With pfmdr1 Polymorphisms
por: Malmberg, Maja, et al.
Publicado: (2013) -
Enantiospecific pharmacokinetics and drug–drug interactions of primaquine and blood-stage antimalarial drugs
por: Chairat, Kalayanee, et al.
Publicado: (2018) -
α(+)Thalassemia Antagonizes the Malaria-protective Effects of Sickle-Cell Trait
por: Amaratunga, Chanaki, et al.
Publicado: (2014)